DMAC Diamedica Therapeutics Inc.

Fundamentals / CIK 0001401040 / USD

Diamedica Therapeutics Inc. reported $36.15M in total assets and a net loss of $40.23M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DMAC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2017 to 2025), reported in USD.

$3.95M$1.98M$0-$30.68MFY 2017 Net Income: -$4.26M2017FY 2018 Revenue: $500KFY 2018 Net Income: -$5.73M2018FY 2019 Net Income: -$10.65M2019FY 2020 Net Income: -$12.29M2020FY 2021 Net Income: -$13.59M2021FY 2022 Net Income: -$13.68M2022FY 2023 Net Income: -$19.38M2023FY 2024 Net Income: -$24.44M2024FY 2025 Net Income: -$32.77M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- -- -- -- $500K --
Research & Development $24.61M $19.06M $13.11M $7.84M $8.77M $8.21M $7.90M $4.52M $3.21M
Total Operating Expenses $34.40M $26.68M $21.27M $14.00M $13.65M $12.70M $11.59M $7.26M $4.52M
Operating Income -$34.40M -$26.68M -$21.27M -$14.00M -$13.65M -$12.70M -$11.59M -$6.76M -$4.52M
EBITDA -$34.35M -$26.64M -$21.24M -$13.98M -$13.62M -$12.68M -$11.57M -$6.75M -$4.51M
Interest Income $1.67M $2.30M $1.95M -- -- -- -- -- --
Income Before Tax -$32.74M -$24.41M -$19.34M -$13.65M -$13.56M -$12.27M -$10.62M -$5.65M -$4.26M
Income Tax Expense $28K $30K $43K $28K $28K $27K $31K $80K --
Net Income -$32.77M -$24.44M -$19.38M -$13.68M -$13.59M -$12.29M -$10.65M -$5.73M -$4.26M
Basic EPS -$0.70 -$0.60 -$0.60 -$0.52 -$0.65 -$0.78 -$0.89 -$0.74 -$0.72
Diluted EPS -- -- -- -- -$0.65 -$0.78 -$0.89 -$0.74 -$0.72
Basic Shares Outstanding 47.0M 40.4M 32.6M 26.4M 20.8M 15.7M 12.0M 7.7M 5.9M
Diluted Shares Outstanding -- -- -- -- 20.8M 15.7M 12.0M 7.7M 5.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $9.24M $8.15M $7.99M $6.70M $6.44M $5.82M $5.66M $6.47M
Operating Income -$11.62M -$10.50M -$10.48M -$9.21M -$9.03M -$8.01M -$8.14M -$8.42M
EBITDA -$11.61M -$10.49M -$10.47M -$9.20M -$9.02M -$8.00M -$8.13M -$8.41M
Interest Income -- -- $470K $472K $440K $313K $444K $543K
Income Before Tax -$11.30M -$10.13M -$10.04M -$8.73M -$8.61M -$7.69M -$7.70M -$7.89M
Income Tax Expense $8.0K $7.0K $7.0K $10K $6.0K $6.0K $6.0K $9.0K
Net Income -$11.31M -$10.14M -$10.04M -$8.74M -$8.62M -$7.70M -$7.71M -$7.90M
Basic EPS -$0.21 -$0.19 -$0.19 -- -$0.17 -$0.18 -$0.18 --
Basic Shares Outstanding 53.9M 53.9M 53.8M -- 49.6M 43.0M 42.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $15.65M $3.02M $4.54M $4.73M $4.71M $7.41M $3.88M $16.82M $1.35M
Short-Term Investments $44.24M $41.12M $48.35M $28.77M $40.41M $20.10M $4.00M -- --
Cash & Short-Term Investments $59.90M $44.10M $52.90M $33.50M $45.11M $27.51M $7.90M $16.82M $1.35M
Accounts Receivable, Net $258K $236K $369K $82K $130K $340K $823K $780K $80K
Total Current Assets $60.63M $44.61M $53.67M $33.84M $45.44M $27.92M $8.84M $17.97M $1.49M
Property, Plant & Equipment, Net $145K $148K $131K $136K $70K $74K $64K $96K $37K
Long-Term Investments -- $0 -- $0 -- -- -- -- --
Total Non-Current Assets $742K $1.74M $485K $560K $112K $174K $217K $367K $308K
Total Assets $61.37M $46.34M $54.16M $34.40M $45.55M $28.09M $9.05M $18.34M $1.80M
Accounts Payable $1.48M $940K $926K $734K $509K $1.10M $182K $483K $513K
Total Current Liabilities $5.13M $5.39M $2.79M $2.17M $1.52M $2.03M $1.32M $1.30M $1.00M
Total Non-Current Liabilities $128K $237K $317K $400K $3.0K $53K $118K $18K $0
Total Liabilities $5.26M $5.63M $3.10M $2.57M $1.53M $2.08M $1.44M $1.31M $1.00M
Total Debt (incl. Leases) $240K $340K $400K $469K $90K $118K $178K $23K --
Common Stock $0 $0 $0 $0 $0 $0 -- -- --
Retained Earnings -$172.8M -$140.0M -$115.6M -$96.18M -$82.50M -$68.91M -$56.62M -$45.97M -$40.23M
Accumulated Other Comp. Income $50K $23K $6.0K -$74K -$51K -$2.0K $2.0K -- --
Total Stockholders' Equity $56.11M $40.72M $51.06M $31.83M $44.02M $26.01M $7.62M $17.02M $799K
Total Equity $56.11M $40.72M $51.06M $31.83M $44.02M $26.01M $7.62M $17.02M $799K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $6.80M $5.13M $4.87M $15.65M $3.33M $4.11M $2.59M $3.02M
Short-Term Investments $28.11M $38.38M $46.46M $44.24M $51.99M $25.93M $33.73M $41.12M
Cash & Short-Term Investments $34.90M $43.50M $51.30M $59.90M $55.30M $30.00M $37.30M $44.10M
Accounts Receivable, Net $176K $244K $301K $258K $260K $161K $253K $236K
Total Current Assets $35.49M $44.31M $52.36M $60.63M $56.22M $31.08M $37.42M $44.61M
Property, Plant & Equipment, Net $131K $133K $142K $145K $150K $152K $149K $148K
Long-Term Investments -- -- -- -- -- -- $1.00M $0
Total Non-Current Assets $661K $686K $717K $742K $824K $391K $1.41M $1.74M
Total Assets $36.15M $45.00M $53.08M $61.37M $57.05M $31.47M $38.83M $46.34M
Accounts Payable $2.65M $2.81M $3.29M $1.48M $1.92M $1.26M $1.51M $940K
Total Current Liabilities $7.45M $6.59M $5.75M $5.13M $5.27M $4.12M $4.67M $5.39M
Total Non-Current Liabilities $40K $69K $97K $128K $157K $184K $211K $237K
Total Liabilities $7.49M $6.66M $5.84M $5.26M $5.42M $4.30M $4.88M $5.63M
Total Debt (incl. Leases) $157K $185K $212K $240K $266K $292K $316K $340K
Common Stock $0 $0 $0 $0 $0 $0 $0 $0
Retained Earnings -$204.3M -$192.9M -$182.8M -$172.8M -$164.0M -$155.4M -$147.7M -$140.0M
Accumulated Other Comp. Income -$55K -$37K -$26K $50K $50K -$14K $5.0K $23K
Total Stockholders' Equity $28.66M $38.34M $47.23M $56.11M $51.62M $27.17M $33.95M $40.72M
Total Equity $28.66M $38.34M $47.23M $56.11M $51.62M $27.17M $33.95M $40.72M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$32.77M -$24.44M -$19.38M -$13.68M -$13.59M -$12.29M -$10.65M -$5.73M -$4.26M
Depreciation & Amortization $43K $39K $30K $25K $24K $21K $21K $15K $4.0K
Stock-Based Compensation $3.85M $2.08M $1.68M $1.50M $1.56M $1.84M $1.16M $620K $409K
Change in Receivables -$22K $133K -$287K $48K $210K $483K -$43K -$700K -$27K
Change in Payables $535K $14K $192K $225K -$590K $917K -$301K -$30K --
Operating Cash Flow -$29.06M -$22.08M -$18.73M -$11.51M -$12.25M -$9.19M -$9.10M -$5.70M -$3.90M
Capital Expenditure -$40K -$25K -$24K -$81K -$22K -$47K -$2.0K -$50K -$22K
Free Cash Flow -$29.10M -$22.10M -$18.75M -$11.59M -$12.27M -$9.23M -$9.10M -$5.75M -$3.92M
Purchases of Investments -$59.28M -$50.41M -$69.41M -$45.68M -$69.81M -$39.75M -$12.92M -- --
Investing Cash Flow -$2.19M $8.56M -$18.30M $11.54M -$20.54M -$16.13M -$3.91M -$50K -$22K
Common Stock Issued $43.28M $11.75M $36.85M $0 $29.85M $28.80M -- $14.73M $2.92M
Financing Cash Flow $43.88M $11.99M $36.84M -$6.0K $30.09M $28.84M $70K $21.22M $3.54M
Net Change in Cash $12.62M -$1.52M -$185K $21K -$2.70M $3.53M -$12.94M $15.47M -$383K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$11.31M -$10.14M -$10.04M -$8.74M -$8.62M -$7.70M -$7.71M -$7.90M
Depreciation & Amortization $12K $12K $11K $11K $18K $3.0K $11K $11K
Stock-Based Compensation $1.53M $1.12M $822K $1.19M $1.02M $771K $867K $589K
Change in Receivables $68K $57K -$43K $2.0K -$99K $92K -$17K $54K
Change in Payables -$166K -$481K $1.82M -$445K $659K -$246K $567K -$231K
Operating Cash Flow -$8.83M -$8.11M -$9.08M -$7.76M -$6.55M -$7.60M -$7.15M -$6.43M
Capital Expenditure -$10K -$3.0K -$8.0K -$6.0K -$16K -$6.0K -$12K -$7.0K
Free Cash Flow -$8.84M -$8.12M -$9.09M -$7.77M -$6.57M -$7.60M -$7.16M -$6.44M
Purchases of Investments -$5.92M -$4.75M -$18.90M -$8.05M -$34.85M -$9.50M -$6.87M -$10.79M
Investing Cash Flow $10.39M $8.24M -$2.11M $8.00M -$25.77M $8.96M $6.62M $5.21M
Financing Cash Flow $114K $132K $417K $12.09M $31.53M $161K $91K $120K
Net Change in Cash $1.67M $261K -$10.78M $12.32M -$783K $1.52M -$436K -$1.11M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -- -- -- -- -1352.2% --
Net Profit Margin -- -- -- -- -- -- -- -1146.8% --
Return on Equity (ROE) -58.4% -60.0% -38.0% -43.0% -30.9% -47.3% -139.8% -33.7% -533.2%
Return on Assets (ROA) -53.4% -52.7% -35.8% -39.8% -29.8% -43.8% -117.6% -31.3% -236.4%
Current Ratio 11.81x 8.28x 19.27x 15.61x 29.82x 13.77x 6.70x 13.87x 1.49x
Quick Ratio 11.72x 8.23x 19.12x 15.49x 29.69x 13.73x 6.62x 13.58x 1.43x
Debt to Equity 0.00x 0.01x 0.01x 0.01x 0.00x 0.00x 0.02x 0.00x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -140.4% -97.9% -74.3% -58.4% -61.8% -108.9% -79.5% -60.0%
Return on Assets (ROA) -111.3% -83.4% -66.1% -53.4% -56.0% -94.0% -69.5% -52.7%
Current Ratio 4.76x 6.72x 9.11x 11.81x 10.67x 7.55x 8.02x 8.28x
Quick Ratio 4.71x 6.63x 8.98x 11.72x 10.55x 7.33x 8.05x 8.23x
Debt to Equity 0.01x 0.00x 0.00x 0.00x 0.01x 0.01x 0.01x 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0001401040) · from December 31, 2017 Data through September 30, 2026 · synced Nov 20, 2026, 05:35 UTC · Open in terminal